Proton therapy in an era of cost containment

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 9, Issue 8, 2011, Pages 821-825

  Herman, Joseph M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; COST CONTROL; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG CANCER; NOTE; PROSTATE CANCER; PROTON THERAPY; QUALITY OF LIFE; RADIATION DOSE; RADIATION RESPONSE; TREATMENT PLANNING; X IRRADIATION;

EID: 80051540506     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2011.0071     Document Type: Note

References (9)

1. Shaw E, Kline R, Gillin M, et al. Radiation therapy oncology group: radiosurgery quality assurance guidelines. Int J Radiat Oncol Biol Phys 1993;27:1231-1239. (Pubitemid 23361609)
2. Timmerman R, Bastasch M, Saha D, et al. Optimizing dose and fractionation for stereotactic body radiation therapy. Normal tissue and tumor control effects with large dose per fraction. Front Radiat Ther Oncol 2007;40:352-365.
3. Chang BK, Timmerman RD. Stereotactic body radiation therapy: a comprehensive review. Am J Clin Oncol 2007;30:637-644. (Pubitemid 350307190)
4. Carlson RW. Industry "rewrites" of NCCN Guidelines. J Natl Compr Canc Netw 2011;9:257.
5. Welsh J, Gomez D, Palmer MB, et al. Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study. Int J Radiat Oncol Biol Phys, in press.
6. Particle Therapy Co-Operative Group. Particle therapy facilities in operation (incl. patient statistics). Available at: http://ptcog.web.psi.ch/ ptcentres.html. Accessed June 21, 2011.
7. Chang JY, Komaki R, Lu C, et al. Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer. Cancer, in press.
8. Lee DW, Rawson JV, Wade SW. Radiology benefit managers: cost saving or cost shifting? J Am Coll Radiol 2011;8:393-401.
9. Goitein M, Cox JD. Should randomized clinical trials be required for proton radiotherapy? J Clin Oncol 2008;26:175-176.